BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 1886889)

  • 1. GLP-1 and GLP-1(7-36) amide: influences on basal and stimulated insulin and glucagon secretion in the mouse.
    Fridolf T; Böttcher G; Sundler F; Ahrén B
    Pancreas; 1991 Mar; 6(2):208-15. PubMed ID: 1886889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
    Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 is a physiological incretin in rat.
    Wang Z; Wang RM; Owji AA; Smith DM; Ghatei MA; Bloom SR
    J Clin Invest; 1995 Jan; 95(1):417-21. PubMed ID: 7814643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbachol priming increases glucose- and glucagon-like peptide-1 (7-36)amide-, but not arginine-induced insulin secretion from the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Arnold R
    Z Gastroenterol; 1990 Jul; 28(7):348-52. PubMed ID: 2238765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice.
    Ahrén B; Gingerich RL; Havel PJ
    Regul Pept; 1995 Nov; 59(3):297-302. PubMed ID: 8577934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide YY: intrapancreatic localization and effects on insulin and glucagon secretion in the mouse.
    Böttcher G; Ahrén B; Lundquist I; Sundler F
    Pancreas; 1989; 4(3):282-8. PubMed ID: 2660131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
    Gromada J; Ding WG; Barg S; Renström E; Rorsman P
    Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro.
    Guenifi A; Ahrén B; Abdel-Halim SM
    Pancreas; 2001 Jan; 22(1):58-64. PubMed ID: 11138972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse.
    Fridolf T; Sundler F; Ahrén B
    Cell Tissue Res; 1992 Aug; 269(2):275-9. PubMed ID: 1423494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is glucagon-like peptide 1 an incretin hormone?
    Nauck MA
    Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas.
    Göke R; Wagner B; Fehmann HC; Göke B
    Res Exp Med (Berl); 1993; 193(2):97-103. PubMed ID: 8516568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.
    Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA
    Am J Physiol; 1995 May; 268(5 Pt 1):E949-55. PubMed ID: 7762650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteroglucagon.
    Holst JJ
    Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin: effects on basal and stimulated insulin and glucagon secretion in the mouse.
    Lindskog S; Ahrén B
    Acta Physiol Scand; 1987 Mar; 129(3):305-9. PubMed ID: 2437768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM.
    Thorens B; Waeber G
    Diabetes; 1993 Sep; 42(9):1219-25. PubMed ID: 8349031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.
    Orskov C; Holst JJ; Nielsen OV
    Endocrinology; 1988 Oct; 123(4):2009-13. PubMed ID: 2901341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
    Heller RS; Aponte GW
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Mukai H; Yamashita K
    Endocrinology; 1989 Dec; 125(6):3109-14. PubMed ID: 2684616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion.
    Deacon CF; Plamboeck A; Møller S; Holst JJ
    Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E873-9. PubMed ID: 11882507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.